Skip to main content
. 2015 Mar 30;2(1):e000025. doi: 10.1136/bmjgast-2014-000025

Table 2.

Patients who took antiviral treatment, stratified by aetiology and disease condition

Aetiology Hepatitis
N (%*)
Cirrhosis
N (%*)
HCC
N (%*)
OLT
N (%*)
Total by aetiology
N (%*)
HCV 42 (12.1) 3 (2.6) 1 (1.9) 16 (2.8) 62 (11.0)
HBV 111 (50.2) 21 (50.0) 10 (83.3) 37 (100) 177 (56.7)
OTHER causes† 3 (3.5) 3 (5.1) 3 (17.6) 11 (25.6) 20 (9.8)
Total by disease condition 156 (23.9) 27 (12.5) 14 (17.1) 64 (49.6) 259 (24.0)

*Percentages are calculated using as denominator the number of patients belonging to each subgroup by aetiology within each subgroup by disease condition (see table 1).

†Other causes included alcoholic liver disease, cholestatic disease and autoimmune disease.

HBV, hepatitis B virus; HCC, hepatocellular carcinoma; OLT, orthotopic liver transplantation.